companydata.dkcompanydata.dk

Abacus Medicine Pharmaceuticals ApS: Financial statements 2021

CVR: 39192063

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

Abacus Medicine Pharmaceuticals ApS (CVR 39192063) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -43,133 and a net result of DKK 2,778,732 compared with DKK 188,314 the year before. Equity in the 2021 report amounted to DKK 25,350,870. The solvency ratio was 28.7%.

Gross Profit
DKK -43,133
Profit/Loss
DKK 2,778,732
Equity
DKK 25,350,870
Total Assets
DKK 88,225,481
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021--43K2.8M25.4M0
2020--63K188K22.6M0
2019--212K548K15.9M0
2018--62K860K15.3M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Abacus Medicine Pharmaceuticals ApS

Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.

Try the lead list generator

Events in 2021

Aposave ApS changes name to Abacus Medicine Pharma Services ApSDec 13, 2021

On December 13, 2021, the company changed its name from Aposave ApS to Abacus Medicine Pharma Services ApS.

Abacus Medicine Pharmaceuticals ApS: The 2020 annual report is outJul 5, 2021

Abacus Medicine Pharmaceuticals ApS has published its annual report for 2020. Gross profit came to DKK -63,479, and the net result was DKK 188,314.

About Abacus Medicine Pharmaceuticals ApS

Abacus Medicine Pharmaceuticals ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2017. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Abacus Medicine Pharma Services ApS and Aposave ApS. The management consists of Flemming Wagner. The company is owned by ABACUS MEDICINE A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -80,000 and a net result of DKK -5,483,000 compared with DKK -2,436,000 the year before. Equity in the 2025 report amounted to DKK 14,264,000.

Source: annual report 2025, Danish Business Authority

Other financial years